MSFT vs NXPI
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
Microsoft exhibits strong fundamental health with a Piotroski F-Score of 7/9, indicating robust financial stability. While the stock is currently experiencing a severe technical downtrend (0/100) and significant 6-month price depreciation (-28.6%), the current price of $374.33 sits well below the growth-based intrinsic value of $471.41 and the analyst target of $587.31. Exceptional earnings growth (59.8% YoY) and high operating margins (47.09%) suggest that the current price correction presents a value opportunity despite bearish insider sentiment.
NXP Semiconductors trades at $197.10, down 10.3% over the past year amid sector-wide semiconductor volatility, yet exhibits strong fundamental resilience and superior profitability relative to peers. Despite near-term revenue contraction (-2.4% YoY), the company maintains best-in-class margins—gross margin of 55.4%, operating margin of 28.24%, and ROE of 20.87%—signaling pricing power and operational efficiency. Forward P/E of 15.08 appears compelling versus sector average P/E of 138.37 and an analyst target price of $258.43, implying 31% upside. Bullish sentiment is reinforced by consistent earnings beats over the last five years and a sustainable 2.06% dividend yield with a 50% payout ratio, though recent insider selling introduces mild caution.
Compare Another Pair
Related Comparisons
MSFT vs NXPI: Head-to-Head Comparison
This page compares Microsoft Corporation (MSFT) and NXP Semiconductors N.V. (NXPI) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.